Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2026-02-04 @ 12:51 AM
Study NCT ID:
NCT00979966
Status:
COMPLETED
Last Update Posted:
2012-07-10
First Post:
2009-09-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib
Sponsor:
Central European Society for Anticancer Drug Research
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
C-II-006 / 2009-010143-13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None